The National Medicines Safety Agency announced this Thursday, November 21, the recall of a batch of generic Atorvastatin Arrow. A tablet of another medicine, prescribed for diabetes, was discovered in a tube.
The wrong medicine in the right box. This Thursday, November 21, the National Medicines Safety Agency (ANSM) and the Arrow Generics laboratory announced the recall of a batch of medications indicated for cholesterol problems. The problem? Another product, prescribed for diabetics, was found for an unspecified reason in a bottle.
“This recall is carried out as a precautionary measure following the detection of a tablet of Gliclazide 30 mg modified release tablets in a bottleAtorvastatin of this batch”, specifies the ANSM in the recall sheet.
Only one case of this issue has been reported at this time. It concerns lot “JBM2300810F”, distributed from February 5, 2024.
“The risk for patients who take gliclazide instead of atorvastatin is hypoglycemia,” specifies the health authority. Thus, certain signs suggestive of a drop in blood sugar levels can alert you: sweating, paleness, abnormal feelings of hunger, dizziness, headaches, etc.
“Do not stop or change your treatment without medical advice”
Instructions are given to people who still have medicines from the problematic batch in their cupboards. “If the reference JBM2300810F is listed, do not stop or change your treatment without medical advice and return your bottle to the pharmacy,” asks the Agency.
For their part, pharmacists must identify the people to whom they were able to deliver the medicine from the batch in question and make contact. “If a patient brings you a vial of Atorvastatin, check that it is part of the lot affected by the recall and replace it with a new compliant vial.”
These incidents are rare but not unprecedented. Last February, BFMTV revealed a recall for a similar story: a hypnotic drug had been discovered in a box of Euphytose, herbal medicine.
